SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-144768
Filing Date
2019-05-13
Accepted
2019-05-13 07:13:30
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d704715d10q.htm 10-Q 427226
2 EX-31.1 d704715dex311.htm EX-31.1 6547
3 EX-31.2 d704715dex312.htm EX-31.2 6514
4 EX-32.1 d704715dex321.htm EX-32.1 3493
5 EX-32.2 d704715dex322.htm EX-32.2 3471
  Complete submission text file 0001193125-19-144768.txt   2905040

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT umrx-20190331.xml EX-101.INS 484145
7 XBRL TAXONOMY EXTENSION SCHEMA umrx-20190331.xsd EX-101.SCH 37788
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE umrx-20190331_cal.xml EX-101.CAL 60057
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE umrx-20190331_def.xml EX-101.DEF 113501
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE umrx-20190331_lab.xml EX-101.LAB 323319
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE umrx-20190331_pre.xml EX-101.PRE 218066
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 19816882
SIC: 2834 Pharmaceutical Preparations